Peng Qinyan, Yao Xiaobin, Xiang Jiexiang, Wang Yuanping, Lin Xinmei
Guangzhou University of Chinese Medicine, Guangzhou, China.
Medicine (Baltimore). 2018 Dec;97(50):e13041. doi: 10.1097/MD.0000000000013041.
Hyperlipidemia is a major risk factor for cardiovascular and cerebrovascular diseases. Acupuncture has been widely applied in the treatment of hyperlipidemia. But its efficacy has not been evaluated scientifically and systematically. Therefore, we provide a protocol of systematic evaluation to assess the effectiveness and safety of acupuncture treatment on patient with hyperlipidemia.
We will search the following databases electronically, including 3 English literature databases (i.e., PubMed, Embase, and Cochrane Library) and 4 Chinese literature databases (i.e., Chinese Biological and Medical database, China National Knowledge Infrastructure, VIP, and Wanfang Database). We will also search randomized-controlled trials about acupuncture treatment for hyperlipidemia and the search time limit is from its establishment to October 2018. The primary outcome is lipid-lowering efficacy. Secondary outcomes are total cholesterol, low-density lipoprotein cholesterol, triglyceride, and high-density lipoprotein cholesterol levels. We will use RevMan V.5.3 software as well to compute the data synthesis carefully when a meta-analysis is allowed.
This study will provide a high-quality synthesis to assess the effectiveness and safety of acupuncture treatment on patient with hyperlipidemia.
The conclusion of our systematic review will provide evidence to judge whether acupuncture is an effective intervention for patient with hyperlipidemia.
高脂血症是心脑血管疾病的主要危险因素。针灸已广泛应用于高脂血症的治疗。但其疗效尚未得到科学系统的评价。因此,我们提供一项系统评价方案,以评估针灸治疗高脂血症患者的有效性和安全性。
我们将通过电子方式检索以下数据库,包括3个英文文献数据库(即PubMed、Embase和Cochrane图书馆)和4个中文文献数据库(即中国生物医学数据库、中国知网、维普和万方数据库)。我们还将检索关于针灸治疗高脂血症的随机对照试验,检索时间限制为从建库至2018年10月。主要结局是降脂疗效。次要结局是总胆固醇、低密度脂蛋白胆固醇、甘油三酯和高密度脂蛋白胆固醇水平。当允许进行荟萃分析时,我们也将使用RevMan V.5.3软件仔细计算数据合成。
本研究将提供高质量的综合分析,以评估针灸治疗高脂血症患者的有效性和安全性。
我们系统评价的结论将为判断针灸是否为高脂血症患者的有效干预措施提供证据。